CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma March 25, 2022March 25, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Roche’s Polivy combination approved by European…FDA accepts supplemental Biologics License…FDA Advisory Committee votes in favour of the…Roche presents new and updated data for Polivy in…Roche’s Polivy combination reduced the risk of…[Ad hoc announcement pursuant to Art. 53 LR] Phase…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
